Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra L Peake

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Critical Care Explorations|October 16, 2025
Relationship Between Phenotyping and Individualized Absolute Risk Differences in Sepsis: A Secondary Analysis of Two Approaches in Two Multicenter TrialsVictor B Talisa, Sachin P Yende, Derek C Angus, et al.
Trials|February 6, 2025
TARGET Protein: the effect of augmented administration of enteral protein to critically ill adults on clinical outcomes-statistical analysis plan for a cluster randomized, cross-sectional, double cross-over, clinical trialSophie Zaloumis, Matthew J Summers, Jeffrey J Presneill, et al.
American Journal of Respiratory and Critical Care Medicine|January 7, 2020
Outcomes Six Months after Delivering 100% or 70% of Enteral Calorie Requirements during Critical Illness (TARGET). A Randomized Controlled TrialAdam M Deane, Lorraine Little, Rinaldo Bellomo, et al.
Critical Care Medicine|October 23, 2024
Heterogeneity in the Effect of Early Goal-Directed Therapy for Septic Shock: A Secondary Analysis of Two Multicenter International TrialsFaraaz Ali Shah, Victor B Talisa, Chung-Chou H Chang, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|October 25, 2023
Study protocol for TARGET protein: The effect of augmented administration of enteral protein to critically ill adults on clinical outcomes: A cluster randomised, cross-sectional, double cross-over, clinical trialMatthew J Summers, Lee-Anne S Chapple, Rinaldo Bellomo, et al.
JAMA|June 11, 2025
Augmented Enteral Protein During Critical Illness: The TARGET Protein Randomized Clinical TrialMatthew J Summers, Lee-Anne S Chapple, Amalia Karahalios, et al.
Intensive Care Medicine|August 21, 2013
Harmonizing international trials of early goal-directed resuscitation for severe sepsis and septic shock: methodology of ProCESS, ARISE, and ProMISe, David T Huang, Derek C Angus, et al.
The New England Journal of Medicine|March 22, 2017
Early, Goal-Directed Therapy for Septic Shock - A Patient-Level Meta-Analysis, Kathryn M Rowan, Derek C Angus, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 10, 2020
The Effect of Renal Replacement Therapy and Antibiotic Dose on Antibiotic Concentrations in Critically Ill Patients: Data From the Multinational Sampling Antibiotics in Renal Replacement Therapy StudyJason A Roberts, Gavin M Joynt, Anna Lee, et al.
Intensive Care Medicine|August 13, 2025
Meropenem and piperacillin/tazobactam optimised dosing regimens for critically ill patients receiving renal replacement therapyJason A Roberts, Marta Ulldemolins, Xin Liu, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Critical Care Explorations|October 16, 2025
Relationship Between Phenotyping and Individualized Absolute Risk Differences in Sepsis: A Secondary Analysis of Two Approaches in Two Multicenter TrialsVictor B Talisa, Sachin P Yende, Derek C Angus, et al.
Trials|February 6, 2025
TARGET Protein: the effect of augmented administration of enteral protein to critically ill adults on clinical outcomes-statistical analysis plan for a cluster randomized, cross-sectional, double cross-over, clinical trialSophie Zaloumis, Matthew J Summers, Jeffrey J Presneill, et al.
American Journal of Respiratory and Critical Care Medicine|January 7, 2020
Outcomes Six Months after Delivering 100% or 70% of Enteral Calorie Requirements during Critical Illness (TARGET). A Randomized Controlled TrialAdam M Deane, Lorraine Little, Rinaldo Bellomo, et al.
Critical Care Medicine|October 23, 2024
Heterogeneity in the Effect of Early Goal-Directed Therapy for Septic Shock: A Secondary Analysis of Two Multicenter International TrialsFaraaz Ali Shah, Victor B Talisa, Chung-Chou H Chang, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|October 25, 2023
Study protocol for TARGET protein: The effect of augmented administration of enteral protein to critically ill adults on clinical outcomes: A cluster randomised, cross-sectional, double cross-over, clinical trialMatthew J Summers, Lee-Anne S Chapple, Rinaldo Bellomo, et al.
JAMA|June 11, 2025
Augmented Enteral Protein During Critical Illness: The TARGET Protein Randomized Clinical TrialMatthew J Summers, Lee-Anne S Chapple, Amalia Karahalios, et al.
Intensive Care Medicine|August 21, 2013
Harmonizing international trials of early goal-directed resuscitation for severe sepsis and septic shock: methodology of ProCESS, ARISE, and ProMISe, David T Huang, Derek C Angus, et al.
The New England Journal of Medicine|March 22, 2017
Early, Goal-Directed Therapy for Septic Shock - A Patient-Level Meta-Analysis, Kathryn M Rowan, Derek C Angus, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 10, 2020
The Effect of Renal Replacement Therapy and Antibiotic Dose on Antibiotic Concentrations in Critically Ill Patients: Data From the Multinational Sampling Antibiotics in Renal Replacement Therapy StudyJason A Roberts, Gavin M Joynt, Anna Lee, et al.
Intensive Care Medicine|August 13, 2025
Meropenem and piperacillin/tazobactam optimised dosing regimens for critically ill patients receiving renal replacement therapyJason A Roberts, Marta Ulldemolins, Xin Liu, et al.
Pageof 9